ALOT

AstroNova is a two-segment industrial hardware micro-cap (Product ID + Aerospace) that has stalled: revenue has been essentially frozen at ~$148–151M for three straight years and actually slipped -0.5% in FY2026, while gross profit fell -6.0% and gross margin sits at a thin 31.6%. The company has now posted two consecutive years of GAAP losses (-$14.5M in FY2025, -$2.38M in FY2026), and ROE is negative at -3.1%. The FY2025 blowup coincides with the May 2024 MTEX (Portugal) acquisition, which is now the subject of arbitration — Effort/Ferreira are claiming €5.2M ($6.1M) for alleged breaches of the acquisition agreement, with AstroNova counterclaiming. That deal looks so far like value destruction plus an open legal overhang, and it is the single biggest scar on the numbers.

The bull case is a genuine operational recovery: the net loss narrowed +83.6% YoY, operating income swung positive to $1.21M (+114%), and — most importantly — operating cash flow surged +142% to $11.7M while capex was slashed -71.5% to just $332K. Liabilities fell -13.1% and equity edged up, so the reported liabilities/equity of 0.79x looks manageable. Management is clearly harvesting cash and paying down obligations rather than investing for growth.